Amneal Pharmaceuticals (FRA:2DT) Current Accrued Expense : €376 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Amneal Pharmaceuticals Current Accrued Expense?

Amneal Pharmaceuticals's Current Accrued Expense for the quarter that ended in Dec. 2024 was €376 Mil.

Amneal Pharmaceuticals's quarterly Current Accrued Expense increased from Jun. 2024 (€324 Mil) to Sep. 2024 (€325 Mil) and increased from Sep. 2024 (€325 Mil) to Dec. 2024 (€376 Mil).

Amneal Pharmaceuticals's annual Current Accrued Expense declined from Dec. 2022 (€291 Mil) to Dec. 2023 (€284 Mil) but then increased from Dec. 2023 (€284 Mil) to Dec. 2024 (€376 Mil).

Amneal Pharmaceuticals Current Accrued Expense Historical Data

The historical data trend for Amneal Pharmaceuticals's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amneal Pharmaceuticals Current Accrued Expense Chart

Amneal Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Accrued Expense

Get a 7-Day Free Trial

315.68

282.68

290.71

284.03

375.86

Amneal Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Current Accrued Expense	Get a 7-Day Free Trial															284.03	301.91	323.99	325.22	375.86

Amneal Pharmaceuticals Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Amneal Pharmaceuticals Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Amneal Pharmaceuticals's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Amneal Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amneal Pharmaceuticals Inc (FRA:2DT) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

AMRX:USA 2DT:Germany

Address

400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ, USA, 08807

Website

https://www.amneal.com

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Amneal Pharmaceuticals Headlines

No Headlines